Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Optic Nerve Glioma 1Gliosarcoma 1Glioma 1Glioblastoma 1Diffuse Intrinsic Pontine Glioma 1Astrocytoma 1

Interventions

Filgrastim 6Carboplatin 5Temozolomide 4Irinotecan 3Ifosfamide 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Busulfan 3Topotecan 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Oxaliplatin 2Melphalan 2Magnetic Resonance Spectroscopy 2Cyproheptadine 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2trioctyl phosphine oxide 1sargramostim 1ixabepilone 1ispinesib 1imetelstat 1gallium Ga 68 dotatate 1fluorodopa F 18 1exatecan 1etoposide phosphate 1becatecarin 1alvocidib 1Vorinostat 1Vincristine 1Verteporfin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Optic Nerve Glioma × Mebendazole × Sarcoma × Clear all
NCT01837862 2024-07-05

A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas

Northwell Health

Phase 1/2 Completed
36 enrolled
CNSSarcoma

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Glioblastoma, Glioma, Gliosarcoma, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡